We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPB
951
DELISTED
Opus Bank Common Stock
OPB
$352K ﹤0.01%
+16,690
New +$352K
TECH icon
952
Bio-Techne
TECH
$11.3B
$348K ﹤0.01%
+6,656
New +$335K
KRG icon
953
Kite Realty
KRG
$5.36B
$344K ﹤0.01%
+22,739
New +$359K
TH icon
954
Target Hospitality
TH
$1.64B
$342K ﹤0.01%
+37,597
New +$381K
SBRA icon
955
Sabra Healthcare REIT
SBRA
$5.37B
$341K ﹤0.01%
+17,303
New +$337K
MODV
956
DELISTED
ModivCare
MODV
$337K ﹤0.01%
5,868
-17,169
-75% -$1.11M
FTNT icon
957
Fortinet
FTNT
$117B
$336K ﹤0.01%
+21,840
New +$360K
CACC icon
958
Credit Acceptance
CACC
$6.08B
$327K ﹤0.01%
+675
New +$321K
TSC
959
DELISTED
TriState Capital Holdings, Inc.
TSC
$327K ﹤0.01%
15,335
-83
-0.5% -$1.82K
FTS icon
960
Fortis
FTS
$28.7B
$324K ﹤0.01%
8,200
-25,200
-75% -$953K
HWC icon
961
Hancock Whitney
HWC
$6.24B
$321K ﹤0.01%
+8,004
New +$330K
RVTY icon
962
Revvity
RVTY
$12.8B
$320K ﹤0.01%
3,324
+2,624
+375% +$244K
PANW icon
963
Palo Alto Networks
PANW
$297B
$319K ﹤0.01%
9,390
-161,040
-94% -$6.02M
SPTN
964
DELISTED
SpartanNash
SPTN
$317K ﹤0.01%
+27,192
New +$388K
FNF icon
965
Fidelity National Financial
FNF
$13.5B
$316K ﹤0.01%
8,148
-33,245
-80% -$1.25M
PINC
966
DELISTED
Premier
PINC
$315K ﹤0.01%
+8,066
New +$291K
RDY icon
967
Dr. Reddy's Laboratories
RDY
$10.2B
$314K ﹤0.01%
+41,895
New +$329K
JEF icon
968
Jefferies Financial Group
JEF
$13.1B
$310K ﹤0.01%
17,995
+7,715
+75% +$132K
HAL icon
969
Halliburton
HAL
$26.6B
$309K ﹤0.01%
13,600
-242,591
-95% -$6.3M
FHI icon
970
Federated Hermes
FHI
$4.72B
$308K ﹤0.01%
+9,489
New +$300K
TWTR
971
DELISTED
Twitter, Inc.
TWTR
$307K ﹤0.01%
8,779
-225,796
-96% -$8.28M
LUV icon
972
Southwest Airlines
LUV
$23B
$304K ﹤0.01%
5,992
-53,338
-90% -$2.76M
AVX
973
DELISTED
AVX Corporation
AVX
$304K ﹤0.01%
18,304
-26,915
-60% -$443K
BN icon
974
Brookfield
BN
$108B
$302K ﹤0.01%
17,657
+3,643
+26% +$61.6K
FTSI
975
DELISTED
FTS International, Inc. Common Stock
FTSI
$300K ﹤0.01%
2,690
+2,383
+776% +$394K
37 38
39
40 41

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.